Literature DB >> 15958832

Genotypes at chromosome 22q12-13 are associated with HIV-1-exposed but uninfected status in Italians.

Yasuyoshi Kanari1, Mario Clerici, Hiroyuki Abe, Hiroyuki Kawabata, Daria Trabattoni, Sergio Lo Caputo, Francesco Mazzotta, Hironori Fujisawa, Atsuko Niwa, Chiaki Ishihara, Yumiko A Takei, Masaaki Miyazawa.   

Abstract

OBJECTIVE: Despite multiple and repeated exposures to HIV-1, some individuals possess no detectable HIV genome and show T-cell memory responses to the viral antigens. HIV-1-reactive mucosal IgA detected in such uninfected individuals suggests their possible immune resistance against HIV. We tested if the above HIV-1-exposed but uninfected status was associated with genetic markers other than a homozygous deletion of the CCR5 gene.
METHODS: Based on our mapping in chromosome 15 of a gene controlling the production of neutralizing antibodies in a mouse retrovirus infection, we genotyped 42 HIV-1-exposed but uninfected Italians at polymorphic loci in the syntenic segment of human chromosome 22, and compared them with 49 HIV-1-infected and 47 uninfected healthy control individuals by a closed testing procedure.
RESULTS: A significant association was found between chromosome 22q12-13 genotypes and a putative dominant locus conferring anti-HIV-1 immune responses in the exposed but uninfected individuals. Distributions of linkage disequilibrium across chromosome 22 also differed between the exposed but uninfected and two other phenotypic groups.
CONCLUSIONS: The data indicated the presence of a new genetic factor associated with the HIV-1-exposed but uninfected status.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15958832     DOI: 10.1097/01.aids.0000174447.48003.dd

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  15 in total

1.  Mapping of susceptibility and protective loci for acute GVHD in unrelated HLA-matched bone marrow transplantation donors and recipients using 155 microsatellite markers on chromosome 22.

Authors:  Tomoki Kikuchi; Taeko K Naruse; Makoto Onizuka; Suyun Li; Tetsuaki Kimura; Akira Oka; Yasuo Morishima; Jerzy K Kulski; Shingo Ichimiya; Noriyuki Sato; Hidetoshi Inoko
Journal:  Immunogenetics       Date:  2007-01-03       Impact factor: 2.846

Review 2.  Host genes associated with HIV/AIDS: advances in gene discovery.

Authors:  Ping An; Cheryl A Winkler
Journal:  Trends Genet       Date:  2010-02-10       Impact factor: 11.639

3.  Persistent Friend virus replication and disease in Apobec3-deficient mice expressing functional B-cell-activating factor receptor.

Authors:  Mario L Santiago; Diana S Smith; Bradley S Barrett; Mauricio Montano; Robert L Benitez; Roberta Pelanda; Kim J Hasenkrug; Warner C Greene
Journal:  J Virol       Date:  2010-10-27       Impact factor: 5.103

4.  Persistence of viremia and production of neutralizing antibodies differentially regulated by polymorphic APOBEC3 and BAFF-R loci in friend virus-infected mice.

Authors:  Sachiyo Tsuji-Kawahara; Tomomi Chikaishi; Eri Takeda; Maiko Kato; Saori Kinoshita; Eiji Kajiwara; Shiki Takamura; Masaaki Miyazawa
Journal:  J Virol       Date:  2010-04-07       Impact factor: 5.103

5.  Innate retroviral restriction by Apobec3 promotes antibody affinity maturation in vivo.

Authors:  Mario L Santiago; Robert L Benitez; Mauricio Montano; Kim J Hasenkrug; Warner C Greene
Journal:  J Immunol       Date:  2010-06-21       Impact factor: 5.422

6.  Mouse APOBEC3 restricts friend leukemia virus infection and pathogenesis in vivo.

Authors:  Eri Takeda; Sachiyo Tsuji-Kawahara; Mayumi Sakamoto; Marc-André Langlois; Michael S Neuberger; Cristina Rada; Masaaki Miyazawa
Journal:  J Virol       Date:  2008-09-10       Impact factor: 5.103

Review 7.  Humoral immunity in the Friend retrovirus infection model.

Authors:  Kalani Halemano; Michael S Harper; Kejun Guo; Sam X Li; Karl J Heilman; Bradley S Barrett; Mario L Santiago
Journal:  Immunol Res       Date:  2013-03       Impact factor: 2.829

8.  Survival after HIV infection in the pre-antiretroviral therapy era in a rural Tanzanian cohort.

Authors:  Raphael Isingo; Basia Zaba; Milly Marston; Milalu Ndege; Julius Mngara; Wambura Mwita; Alison Wringe; David Beckles; John Changalucha; Mark Urassa
Journal:  AIDS       Date:  2007-11       Impact factor: 4.177

9.  Differential requirements of cellular and humoral immune responses for Fv2-associated resistance to erythroleukemia and for regulation of retrovirus-induced myeloid leukemia development.

Authors:  Sachiyo Tsuji-Kawahara; Hiroyuki Kawabata; Hideaki Matsukuma; Saori Kinoshita; Tomomi Chikaishi; Mayumi Sakamoto; Yuri Kawasaki; Masaaki Miyazawa
Journal:  J Virol       Date:  2013-10-09       Impact factor: 5.103

10.  Apobec3 encodes Rfv3, a gene influencing neutralizing antibody control of retrovirus infection.

Authors:  Mario L Santiago; Mauricio Montano; Robert Benitez; Ronald J Messer; Wes Yonemoto; Bruce Chesebro; Kim J Hasenkrug; Warner C Greene
Journal:  Science       Date:  2008-09-05       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.